Page 316 - Read Online
P. 316

Page 2 of 14         Darbinyan et al. Neuroimmunol Neuroinflammation 2018;5:41  I  http://dx.doi.org/10.20517/2347-8659.2018.33


               INTRODUCTION
               The Vipers are the lone family of venomous snakes found in Armenia. The main action of viper venoms is
               related to protein-degrading proteases, which cause local necrosis, systemic cardiovascular damage, and
                                                  [1]
               disruption of the blood-clotting system . The whole venom of Caucasian Levantine viper [syn.: blunt-
               nosed viper, Macrovipera lebetina obtusa (MLO)] contains many enzymatically active proteins and different
               polypeptides [Figure 1] with a variety of effects on cells and organs, including pronounced hemorrhagic
                                                                                                  [4,5]
                    [2,3]
               effect . Macrovipera lebetina species venom contains snake venom metalloproteinases (SVMP)  which
                                    2+
                     2+
               are Zn -containing, Ca -dependent enzymes that differ in domain structure: some of them contain just
               metalloproteinase domain, others contain metalloproteinase domain and non-catalytic domains. MLO
                                                                            [2]
               venom contains only two out of four types of SVMPs: P-I and P-III . Metalloproteinase P-I has only
                             [6,7]
               catalytic domain  and consitutes more than one-quarter of the whole MLO venom.
                                                                                                    [6,8]
               The P-III is characterized by proteolytic enzyme property, high ability to bind to the substrate  and
                                                         [9]
               high hemorrhagic activity (with rare exceptions ). Together PI and PIII are making up approximately
               one-third of the entire contents of the MLO venom. SVMPs, which are secretory proteinases, cause
               hemorrhagic injuries, splitting the components of the basement membrane and disrupting their interaction
                                 [10]
               with endothelial cells . In addition, they induce muscle necrosis, skin damage, and inflammation. Some
                                                                           [11]
               SVMPs induce apoptosis in human umbilical vein endothelial cells . Moreover, SVMPs interact with
               matrix metalloproteinases (MMPs) of a prey. MMPs are carrying out tissue remodeling, angiogenesis, cell
                                                                                        [12]
               proliferation, migration, differentiation, apoptosis, and in curbing the growth of tumors . They are involved
               in the cleavage of membrane receptors, ligand release, as well as in the activation/deactivation of the
                                     [13]
               chemokines and cytokines . SVMP P-I and P-III can trigger secretion of prey’s MMP-2 and MMP-9, which
                                                                               [4]
               together with venom MPs may destroy extracellular matrix or VE-cadherins . These and other cadherins (β
                                                                        [11]
               and γ) are denatured leading to increased intracellular permeability . During such damage of brain tissue,
               microglia plays a critical role in the protection of brain from the action of harmful factors of the venom [14-16] .

               Mechanisms by which different doses of snake venom, and particularly, SVMPs affect or disrupt the
               microvasculature of brain and cause hemorrhage have not been fully elucidated. The goal of our investigation
               was to assess hemorrhagic effects of MLO venom on rat brain given at different doses and for different
               periods when administered via intraperitoneal (IP) route.


               METHODS
               Animals
               This study was conducted in accordance with “Principles of Laboratory Animal Care” and as carried out in
               accordance with the European Communities Council Directive of September 22 2010 (2010/63/EU). Sixty-
               two adult Wistar albino male rats were used in this study.

               Reagents
               MLO venom was milked and dried in the Laboratory of Physiologically Active Substances Purification,
               Certification and Standardization (PAS PCS) of Orbeli Institute of Physiology of National Academy of
               Sciences of Armenia. Snakes were supplied by the licensed catcher “GEBEVSS” Ltd., Armenia. Other
               reagents were purchased from “Sigma-Aldrich”, “Merck” “Reanal” and “H. Lundbeck A/S” companies as
               indicated. All other chemicals were of analytical or sequencing grade.

               Verification of venom hemorrhagic activity in vivo
                                                                                                [17]
               The hemorrhagic activity of SVMPs was tested in vivo by a modified method of Kondo et al. . In brief,
                                                                                                         2
               2 rats (around 250 g) were anesthetized with Nembutal (pentobarbital, at a dose of 40 mg/kg) and 4 cm
               of dorsal skin was chemically depilated (“Veet”, Reckitt and Benckizer, France). 0.1 mL aliquots of a
   311   312   313   314   315   316   317   318   319   320   321